ANYGEN CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,790 KRW | -2.57% |
|
-7.62% | +0.61% |
| 04-05 | Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding | CI |
| 03-28 | Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 69,223 | 50,663 | 69,223 | 85,999 | 41,515 | 87,278 |
| Enterprise Value (EV) 1 | 67,781 | 54,775 | 76,304 | 88,281 | 48,469 | 93,613 |
| P/E ratio | -9.65 x | -7.62 x | -28.1 x | -47.5 x | -6.69 x | -9.22 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 16.8 x | 8.07 x | 8.13 x | 8.38 x | 4.79 x | 15.6 x |
| EV / Revenue | 16.5 x | 8.73 x | 8.96 x | 8.6 x | 5.6 x | 16.7 x |
| EV / EBITDA | -17.8 x | -24.7 x | 58.1 x | 37.6 x | -35.1 x | -24.3 x |
| EV / FCF | -7.24 x | -12.3 x | 84.6 x | -40.3 x | -13.4 x | -48.5 x |
| FCF Yield | -13.8% | -8.13% | 1.18% | -2.48% | -7.45% | -2.06% |
| Price to Book | 3.24 x | 3.38 x | 5.65 x | 4.39 x | 3.1 x | 8.3 x |
| Nbr of stocks (in thousands) | 5,016 | 5,016 | 5,016 | 5,603 | 5,603 | 5,937 |
| Reference price 2 | 13,800 | 10,100 | 13,800 | 15,350 | 7,410 | 14,700 |
| Announcement Date | 31/12/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4,114 | 6,277 | 8,516 | 10,267 | 8,662 | 5,611 |
| EBITDA 1 | -3,813 | -2,214 | 1,313 | 2,346 | -1,381 | -3,849 |
| EBIT 1 | -5,151 | -4,260 | -1,047 | -321.4 | -4,325 | -6,717 |
| Operating Margin | -125.2% | -67.87% | -12.29% | -3.13% | -49.93% | -119.71% |
| Earnings before Tax (EBT) 1 | -8,320 | -6,645 | -2,462 | -1,690 | -6,205 | -9,079 |
| Net income 1 | -7,164 | -6,645 | -2,462 | -1,690 | -6,205 | -9,079 |
| Net margin | -174.12% | -105.86% | -28.91% | -16.46% | -71.63% | -161.82% |
| EPS 2 | -1,430 | -1,325 | -490.8 | -323.4 | -1,107 | -1,595 |
| Free Cash Flow 1 | -9,360 | -4,456 | 902.4 | -2,192 | -3,611 | -1,929 |
| FCF margin | -227.5% | -70.98% | 10.6% | -21.35% | -41.69% | -34.39% |
| FCF Conversion (EBITDA) | - | - | 68.71% | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 31/12/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 4,112 | 7,081 | 2,281 | 6,954 | 6,335 |
| Net Cash position 1 | 1,442 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -1.857 x | 5.392 x | 0.9726 x | -5.035 x | -1.646 x |
| Free Cash Flow 1 | -9,360 | -4,456 | 902 | -2,192 | -3,611 | -1,929 |
| ROE (net income / shareholders' equity) | -31.6% | -36.5% | -18.1% | -10.6% | -37.6% | -75.9% |
| ROA (Net income/ Total Assets) | -10.6% | -8.05% | -2.11% | -0.63% | -9.27% | -17.9% |
| Assets 1 | 67,713 | 82,548 | 116,604 | 267,770 | 66,916 | 50,699 |
| Book Value Per Share 2 | 4,265 | 2,989 | 2,441 | 3,499 | 2,391 | 1,772 |
| Cash Flow per Share 2 | 296.0 | 153.0 | 218.0 | 221.0 | 85.70 | 171.0 |
| Capex 1 | 9,266 | 3,032 | 482 | 838 | 1,552 | 127 |
| Capex / Sales | 225.22% | 48.31% | 5.67% | 8.16% | 17.92% | 2.26% |
| Announcement Date | 31/12/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +0.61% | 65.62M | |
| +33.00% | 693B | |
| +29.39% | 584B | |
| -3.13% | 372B | |
| +20.30% | 332B | |
| +6.47% | 294B | |
| +14.13% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.04% | 168B |
- Stock Market
- Equities
- A196300 Stock
- Financials Anygen Co., Ltd.
